Collecting data on Taperloc Complete stems for hip surgeries
Official title: Post Market Clinical Follow up Study to Provide Safety, Performance and Clinical Benefits Data of the Taperloc Complete Stems
Run by Zimmer Biomet · NCT04028687 · Data updated 2026-11-12
This study is trying to see how safe and effective the Taperloc Complete hip implants are for people who have had hip surgery, by looking at both past patients and following new ones over the years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 820 (estimated) |
| Sponsor | Zimmer Biomet Industry-sponsored |
| Locations | 3 sites (Henderson, Nevada and 2 other locations) |
| Status | Recruiting |
| Started | February 13, 2020 |
| Main results expected | February 12, 2032 |
| Study ends | February 12, 2032 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT04028687 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who have undergone primary or revision hip arthroplasty with Taperloc Complete stems for various hip conditions.
✕Probably not a fit
Patients with infections, sepsis, or other significant medical conditions that could impair healing or complicate the surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather data on the safety, performance, and clinical benefits of Taperloc Complete stems used in primary or revision total hip arthroplasty. It will involve both retrospective data collection from patients who have already undergone the procedure and prospective follow-up at 1, 3, 5, 7, and 10 years post-surgery. The study will assess the incidence of complications and revisions while also evaluating patient-reported outcomes to determine the clinical benefits of the implants.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term safety and effectiveness of Taperloc Complete stems, potentially improving patient outcomes in hip surgeries.
How similar studies have gone: Other studies on hip arthroplasty implants have shown success in confirming safety and performance, making this approach well-supported by existing literature.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient must be 18 years of age or older and skeletally mature * Patient must be willing and able to sign IRB approved informed consent * Patient must have undergone primary or revision hip arthroplasty with the -Taperloc Complete stem according to a cleared indication, which includes the following: * Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis * Rheumatoid arthritis * Correction of functional deformity * Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques Exclusion Criteria: * Off-label use * Infection * Sepsis * Osteomyelitis * Uncooperative patient or patient with neurologic disorders who are incapable of following directions * Osteoporosis * Metabolic disorders which may impair bone formation * Osteomalacia * Distant foci of infections which may spread to the implant site * Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram * Vascular insufficiency, muscular atrophy, or neuromuscular disease * Patient is known to be pregnant or nursing * Patient is a prisoner * Patient is a known alcohol or drug abuser * Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent
Where it's running
-
Texas Health Physicians Group
Plano, Texas, United States Recruiting -
Orthopaedic Institute of Henderson
Henderson, Nevada, United States Withdrawn -
Proliance Orthopaedics and Sports Medicine
Bellevue, Washington, United States Withdrawn
Study contacts
- Study coordinator: Megan McKinnie
- Email: megan.mckinnie@zimmerbiomet.com
- Phone: +1 (919) 381-7091
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mobile app to help recovery after hip, knee, or spine surgery
We will test a mobile app that prompts in-bed conditioning exercises to help people over 65 recover after hip fracture fixation, spinal fusion, or total hip/knee replacement.
-
Patient-centered education after hip fracture surgery
A structured education program after hip fracture surgery is being tested to see if it helps patients recover better than routine care alone.
-
PENG Block Compared with Femoral Nerve Block for Spinal Anesthesia in Hip Fracture Surgery
This trial tests whether the ultrasound-guided Pericapsular Nerve Group (PENG) block helps when positioning for spinal anesthesia in older adults with hip fractures, compared with the standard femoral nerve block.
-
French version validation of the New Mobility Score for older adults after hip fracture
This study tests whether the French version of the New Mobility Score accurately measures mobility in French patients aged 75 and older after hip fracture.
-
Hip arthroplasty with a short cementless stem using a direct anterior approach
This study tests whether a short, cementless hip stem implanted through a minimally invasive direct anterior approach works well in adults with hip arthritis.
-
Two online pain-management programs for adults with chronic non-arthritic hip pain
This study tests whether two video-delivered programs for hip pain are feasible for adults with chronic, non-arthritic hip pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.